Exploring the pH-dependent structure-dynamics-function relationship of human renin

Renin is a pepsin-like aspartyl protease and an important drug target for the treatment of hypertension; despite three decades’ research, its pH-dependent structure-function relationship remains poorly understood. Here we employed the continuous constant pH molecular dynamics (CpHMD) simulations to decipher the acid/base roles of renin’s catalytic dyad and the conformational dynamics of the flap, which is a common structural feature among aspartyl proteases. The calculated pKa’s suggest that the catalytic Asp38 and Asp226 serve as the general base and acid, respectively, in agreement with experiment and supporting the hypothesis that renin’s neutral optimum pH is due to the substrate-induced pKa shifts of the aspartic dyad. The CpHMD data confirmed our previous hypothesis that hydrogen bond formation is the major determinant of the dyad pKa order. Additionally, our simulations showed that renin’s flap remains open regardless of pH, although a Tyr-inhibited state is occasionally formed above pH 5. These findings are discussed in comparison to the related aspartyl proteases, including β-secretases 1 and 2, capthepsin D, and plasmepsin II. Our work represents a first step towards a systematic understanding of the pH-dependent structure-dynamics-function relationships of pepsin-like aspartyl proteases that play important roles in biology and human disease states.

[1]  Jana K. Shen,et al.  Continuous Constant pH Molecular Dynamics in Explicit Solvent with pH-Based Replica Exchange. , 2011, Journal of chemical theory and computation.

[2]  Alexander Wlodawer,et al.  An unusual orientation for Tyr75 in the active site of the aspartic proteinase from Saccharomyces cerevisiae. , 2002, Biochemical and biophysical research communications.

[3]  Jana K. Shen,et al.  Predicting Catalytic Proton Donors and Nucleophiles in Enzymes: How Adding Dynamics Helps Elucidate the Structure-Function Relationships. , 2018, The journal of physical chemistry letters.

[4]  G. Ullmann,et al.  Relations between Protonation Constants and Titration Curves in Polyprotic Acids: A Critical View , 2003 .

[5]  D. Egan,et al.  Characterization of recombinant human renin: Kinetics,pH-stability, and peptidomimetic inhibitor binding , 1991, Journal of protein chemistry.

[6]  T. Darden,et al.  A smooth particle mesh Ewald method , 1995 .

[7]  Hans Matter,et al.  Structure-based optimization of potent 4- and 6-azaindole-3-carboxamides as renin inhibitors. , 2011, Bioorganic & medicinal chemistry letters.

[8]  E. Jacoby,et al.  The discovery of novel potent trans-3,4-disubstituted pyrrolidine inhibitors of the human aspartic protease renin from in silico three-dimensional (3D) pharmacophore searches. , 2013, Journal of medicinal chemistry.

[9]  Natércia F. Brás,et al.  Molecular dynamics studies on both bound and unbound renin protease , 2014, Journal of biomolecular structure & dynamics.

[10]  J. Gierse,et al.  Substrate specificity of recombinant human renal renin: effect of histidine in the P2 subsite on pH dependence. , 1990, Biochemistry.

[11]  Wei Chen,et al.  Recent development and application of constant pH molecular dynamics , 2014, Molecular simulation.

[12]  Silvio C. E. Tosatto,et al.  InterPro in 2019: improving coverage, classification and access to protein sequence annotations , 2018, Nucleic Acids Res..

[13]  Robert C. Harris,et al.  How Ligand Protonation State Controls Water in Protein-Ligand Binding. , 2018, The journal of physical chemistry letters.

[14]  F. Suzuki,et al.  Ser84 of Human Renin Contributes to the Biphasic pH Dependence of the Renin-Angiotensinogen Reaction , 2007, Bioscience, biotechnology, and biochemistry.

[15]  Natércia F. Brás,et al.  The catalytic mechanism of mouse renin studied with QM/MM calculations. , 2012, Physical chemistry chemical physics : PCCP.

[16]  S. Bhakat,et al.  Flap Dynamics in Aspartic Proteases: A Computational Perspective , 2016, Chemical biology & drug design.

[17]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[18]  Shankar Venkatraman,et al.  Structure-based design of β-site APP cleaving enzyme 1 (BACE1) inhibitors for the treatment of Alzheimer's disease. , 2013, Journal of medicinal chemistry.

[19]  C. Behnke,et al.  Discovery of TAK-272: A Novel, Potent, and Orally Active Renin Inhibitor , 2016, ACS medicinal chemistry letters.

[20]  Alexander D. MacKerell,et al.  Improved treatment of the protein backbone in empirical force fields. , 2004, Journal of the American Chemical Society.

[21]  Natércia F. Brás,et al.  Reaction Mechanism of Human Renin Studied by Quantum Mechanics/Molecular Mechanics (QM/MM) Calculations , 2014 .

[22]  R E Cachau,et al.  Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[23]  L. Zisman.  ACE and ACE2: a tale of two enzymes , 2005, European heart journal.

[24]  F. Suzuki,et al.  The Coexistence of Ser84 in Renin and His13 in Angiotensinogen Brings a pH Profile of Two Separate Peaks to the Reaction of Human Renin and Sheep Angiotensinogen , 2008, Bioscience, biotechnology, and biochemistry.

[25]  Marc A Pfeffer,et al.  Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19 , 2020, The New England journal of medicine.

[26]  J. Staessen,et al.  Oral renin inhibitors , 2006, The Lancet.

[27]  Alexander D. MacKerell,et al.  All-atom empirical potential for molecular modeling and dynamics studies of proteins. , 1998, The journal of physical chemistry. B.

[28]  A. Caflisch,et al.  Functional Plasticity in the Substrate Binding Site of β-Secretase , 2005 .

[29]  C. Schnell,et al.  Structural modification of the P2' position of 2,7-dialkyl-substituted 5(S)-amino-4(S)-hydroxy-8-phenyl-octanecarboxamides: the discovery of aliskiren, a potent nonpeptide human renin inhibitor active after once daily dosing in marmosets. , 2007, Journal of medicinal chemistry.

[30]  Zhongren Wu,et al.  Purification and characterization of recombinant human renin for X-ray crystallization studies , 2008, BMC Biochemistry.

[31]  Jianpeng Ma,et al.  CHARMM: The biomolecular simulation program , 2009, J. Comput. Chem..

[32]  David A. Calhoun,et al.  Drugs targeting the renin–angiotensin–aldosterone system , 2002, Nature Reviews Drug Discovery.

[33]  N. Andreeva,et al.  Analysis of crystal structures of aspartic proteinases: On the role of amino acid residues adjacent to the catalytic site of pepsin‐like enzymes , 2001, Protein science : a publication of the Protein Society.

[34]  K. Takahashi,et al.  Two peaks in pH dependence of renin-angiotensinogen reaction. , 1998, Bioscience, biotechnology, and biochemistry.

[35]  G. Gilliland,et al.  Can enzymes adopt a self-inhibited form? Results of x-ray crystallographic studies of chymosin. , 1992, Biochemical and biophysical research communications.

[36]  Ketopiperazine-based renin inhibitors: optimization of the "C" ring. , 2006, Bioorganic & medicinal chemistry letters.

[37]  Jana K. Shen,et al.  Charge-leveling and proper treatment of long-range electrostatics in all-atom molecular dynamics at constant pH. , 2012, The Journal of chemical physics.

[38]  Christopher R. Ellis,et al.  pH-Dependent Population Shift Regulates BACE1 Activity and Inhibition. , 2015, Journal of the American Chemical Society.

[39]  J D Baxter,et al.  Structure of recombinant human renin, a target for cardiovascular-active drugs, at 2.5 A resolution. , 1989, Science.

[40]  F. Suzuki,et al.  Tyrosine-83 of human renin contributes to biphasic pH dependence of the renin-angiotensinogen reaction. , 1999, Bioscience, biotechnology, and biochemistry.

[41]  L. Tong,et al.  Crystallographic Studies on the Binding Modes of P2-P3 Butanediamide Renin Inhibitors (*) , 1995, The Journal of Biological Chemistry.

[42]  P. Drawz,et al.  Advances in understanding the renin-angiotensin-aldosterone system (RAAS) in blood pressure control and recent pivotal trials of RAAS blockade in heart failure and diabetic nephropathy , 2017, F1000Research.

[43]  Cheng-Chieh Tsai,et al.  Conformational dynamics of cathepsin D and binding to a small‐molecule BACE1 inhibitor , 2017, J. Comput. Chem..